Cboe’s Robust Quarterly Results Might Change the Case For Investing In Cboe Global Markets (CBOE)

• Cboe Global Markets recently reported higher quarterly revenue and net profit compared to the prior year, drawing continued coverage from major analysts such as RBC Capital, Bank of America Securities, and Piper Sandler.
• The company's ability to improve both top-line and bottom-line results highlights the effectiveness of its efforts in expanding across derivatives, data, and global trading segments.
• We'll explore how Cboe's improved financial performance might reinforce its investment narrative and outlook for expanding global trading activity.

The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

Cboe Global Markets Investment Narrative Recap

To be a shareholder in Cboe Global Markets, one must believe in the continued secular growth of global electronic trading, especially in derivatives and data, and trust that Cboe can sustain its competitive advantages while successfully executing on strategic expansion. The recently reported rise in both revenue and net profit signals operational momentum, but this alone may not fundamentally change the biggest short-term catalyst, trading volume expansion, nor does it materially reduce the concentration risk tied to Cboe’s reliance on its S&P index options franchise.

Among recent company announcements, the upcoming Q3 2025 earnings release stands out as most directly relevant to the latest results, offering investors a new checkpoint on growth progress in Cboe's core and emerging business lines. As management continues to emphasize product innovation and global reach, this earnings update arrives at a time when both catalysts and potential risks around expansion and market concentration are in sharp focus.

In contrast, the concentration risk around Cboe's S&P partnership remains a factor investors should be aware of, especially as...

Read the full narrative on Cboe Global Markets (it's free!)

Cboe Global Markets' outlook anticipates $2.6 billion in revenue and $1.1 billion in earnings by 2028. This scenario is based on an annual revenue decline of 16.9% and an earnings increase of $203.7 million from the current earnings of $896.3 million.

Uncover how Cboe Global Markets' forecasts yield a $247.47 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members provided eight separate fair value estimates for Cboe, ranging from US$41.96 to US$247.47, showcasing wide-ranging opinions. With trading volume growth still top of mind, you can see how much market participants differ when assessing Cboe’s future performance, review more of these viewpoints to broaden your perspective.

Explore 8 other fair value estimates on Cboe Global Markets - why the stock might be worth as much as 6% more than the current price!

Build Your Own Cboe Global Markets Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Cboe Global Markets research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Cboe Global Markets research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cboe Global Markets' overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• We've found 17 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com